As of September 2026, SPDR S&P BIOTECH ETF is classified as not halal.
NOT HALAL
Is SPDR S&P BIOTECH ETF Halal?
Shariah Compliance Analysis of XBI ETF
US Equity Health Care
No. As of September 2026, SPDR S&P BIOTECH ETF (XBI) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. SPDR S&P BIOTECH ETF does not pass Musaffa's business and financial screening criteria.
XBI was created on 2006-01-31 by SPDR. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 8442.95m in AUM and 148 holdings. XBI tracks an equal-weighted index of US biotechnology stocks.
SPDR S&P BIOTECH ETF (XBI) Chart
Key Statistics of SPDR S&P BIOTECH ETF (XBI)
Today's Open
-
AUM
-
Avg. Volume
-
Expense Ratio
-
P/E Ratio
-
P/B Ratio
-
Sector Exposure
Health Care
99.91%
Other
0.09%
FAQ's for SPDR S&P BIOTECH ETF (XBI)
As of September 2026, SPDR S&P BIOTECH ETF XBI is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes SPDR S&P BIOTECH ETF using these criteria to determine its compliance status.
The Shariah compliance status of SPDR S&P BIOTECH ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
You can check the latest Shariah compliance status of SPDR S&P BIOTECH ETF on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.